AR120803A1 - SOLID FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXI-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-IL]PIPERIDINE-1-CARBONYL]-4-METHYL -4-[4-(OXETAN-3-IL)PIPERAZIN-1-IL]PENT-2-ENENITRILE - Google Patents

SOLID FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXI-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-IL]PIPERIDINE-1-CARBONYL]-4-METHYL -4-[4-(OXETAN-3-IL)PIPERAZIN-1-IL]PENT-2-ENENITRILE

Info

Publication number
AR120803A1
AR120803A1 ARP200103533A ARP200103533A AR120803A1 AR 120803 A1 AR120803 A1 AR 120803A1 AR P200103533 A ARP200103533 A AR P200103533A AR P200103533 A ARP200103533 A AR P200103533A AR 120803 A1 AR120803 A1 AR 120803A1
Authority
AR
Argentina
Prior art keywords
phenoxi
enenitrile
oxetan
pent
pyrazolo
Prior art date
Application number
ARP200103533A
Other languages
Spanish (es)
Inventor
Zhu Jiang
Katherine Chu
Kolbot By
Mohammad Masjedizadeh
Pasit Phiasivongsa
Original Assignee
Principia Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Principia Biopharma Inc filed Critical Principia Biopharma Inc
Publication of AR120803A1 publication Critical patent/AR120803A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Formas sólidas del compuesto de fórmula (1) se describen. También se describen composiciones farmacéuticas que los comprenden, métodos para tratar desórdenes y condiciones mediadas por actividad de BTK usando los mismos, y métodos para preparar el Compuesto de fórmula (1) y formas cristalinas de este.Solid forms of the compound of formula (1) are described. Pharmaceutical compositions comprising them, methods of treating disorders and conditions mediated by BTK activity using the same, and methods of preparing the Compound of formula (1) and crystalline forms thereof are also described.

ARP200103533A 2019-12-20 2020-12-17 SOLID FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXI-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-IL]PIPERIDINE-1-CARBONYL]-4-METHYL -4-[4-(OXETAN-3-IL)PIPERAZIN-1-IL]PENT-2-ENENITRILE AR120803A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201962951958P 2019-12-20 2019-12-20

Publications (1)

Publication Number Publication Date
AR120803A1 true AR120803A1 (en) 2022-03-16

Family

ID=80994923

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP200103533A AR120803A1 (en) 2019-12-20 2020-12-17 SOLID FORMS OF 2-[3-[4-AMINO-3-(2-FLUORO-4-PHENOXI-PHENYL)PYRAZOLO[3,4-D]PYRIMIDIN-1-IL]PIPERIDINE-1-CARBONYL]-4-METHYL -4-[4-(OXETAN-3-IL)PIPERAZIN-1-IL]PENT-2-ENENITRILE

Country Status (1)

Country Link
AR (1) AR120803A1 (en)

Similar Documents

Publication Publication Date Title
CL2021003012A1 (en) nlrp3 inflammasome inhibitors
NI201900070A (en) HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS
DOP2021000019A (en) INFLAMASOME INHIBITORS NLRP3
UY37537A (en) PIRAZOL DERIVATIVES AS MALT1 INHIBITORS
UY39723A (en) CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR MODULATOR, PHARMACEUTICAL COMPOSITIONS, TREATMENT METHODS AND PROCESS FOR PRODUCING THE MODULATOR
ECSP20001149A (en) ANTIPROLIFERATIVE COMPOUNDS AND METHODS TO USE THEM
CO2022002759A2 (en) hpk1 antagonists and their uses
EA202092490A1 (en) METHYL-MODIFYING ENZYMES MODULATORS, COMPOSITIONS AND THEIR APPLICATION
PE20190811A1 (en) DERIVATIVES OF PYRAZOLOPYRIMIDINES AS A KINASE INHIBITOR
EA201892450A1 (en) AROMATIC SULPHONAMIDE DERIVATIVES
UY32462A (en) NEW BIFENYLL DERIVATIVES FOR HEPATITIS C 644 VIRUS INFECTION TREATMENT
ECSP066302A (en) OMEGA-CARBOXIARIL-DIFENIL-UREA REPLACED WITH FLUORINE FOR THE TREATMENT AND PREVENTION OF DISEASES AND AFFECTIONS
BR112021025964A2 (en) Bempedoic acid salt forms and methods for using them
CU20170026A7 (en) COMPOUNDS DERIVED FROM 2- (BENZAMIDO / PICOLINAMIDO / NICOTINAMIDO / ISONICOTINAMIDO) - (2-METHYL-6-MORPHOLINO- (PHENYL / (3,4´-BIPIRIDIN)) - 2-IL) OXI) ETHYL DIHYDROGEN PHOSPHATE AS INHIBITORS OF INHIBITORS RAF
PE20170946A1 (en) 2-AMINO-6- (DIFLUOROMETIL) - 5,5-DIFLUORO-6-PHENYL-3,4,5,6-TETRAHYDROPYRIDINES AS BACE1 INHIBITORS
DOP2016000308A (en) COMPOUNDS OF 1, 3, 4-TIADIAZOL AND USE OF THE SAME FOR THE TREATMENT OF CANCER
EA202191519A1 (en) TREX1 MODULATORS
CO2018007278A2 (en) Metaazacyclic aminobenzoic acid derivatives as pan integrin antagonists
UY38716A (en) HERBICIDALLY ACTIVE ISOXAZOLINE DERIVATIVES, AND PROCESSES AND INTERMEDIARIES USED FOR THE PREPARATION OF THESE DERIVATIVES
CL2021003455A1 (en) 3-(5-methyl-1,3-thiazol-2-1 l)-n--{(1 r)-1-[2-(trifluoro-methyl)pyrimidin-5-yl]ethyl}benzamide analogs
CL2020003227A1 (en) Small molecule inhibitors of the jak kinase family.
CO2022009916A2 (en) Crystal forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1h-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-carbonyl]- 4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
AR125457A2 (en) DUAL MAGL AND FAAH INHIBITOR COMPOUNDS AND PHARMACEUTICAL COMPOSITION
CO2017001523A2 (en) Novel 2,5-substituted pyrimidines
CU20160148A7 (en) AZOL COMPOUNDS REPLACED WITH AMIDA AS INHIBITORS OF TNKS1 AND / OR TNKS2